The faster the weight loss, the more collagen is lost. Despite volume loss being the skin side effect dominating the public discourse, there are other, less-discussed changessuch as dryness and dullnessthat most people on a GLP-1 experience
Here, we show that semaglutide also exhibits limited brain access following peripheral administration, which is unlikely to be driven by general permeation of the BBB
Commercializing CagriSema, if approved, could be challenging
Retatrutides GLP-1 activity reduces hunger and slows gastric emptying, making large protein-rich meals difficult to tolerate
Clinical trials show headache rates of approximately 6-8% with diabetes doses and over 10% with higher weight-management doses
This is a common concern for patients prescribed this oral diabetes medication